IWP
LLY icon

Invenio Wealth Partners’s Eli Lilly LLY Stock Holding History

Invenio Wealth Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Buy
1,173
+21
+2% +$21.5K 0.5% 31
2026
Q1 		$1.06M Sell
1,152
-60
-5% -$60.8K 0.42% 34
2025
Q4 		$1.3M Sell
1,212
-104
-8% -$99.4K 0.48% 32
2025
Q3 		$1M Sell
1,316
-32
-2% -$23.8K 0.37% 39
2025
Q2 		$1.05M Sell
1,348
-216
-14% -$168K 0.42% 36
2025
Q1 		$1.29M Sell
1,564
-45
-3% -$37.4K 0.54% 31
2024
Q4 		$1.24M Buy
1,609
+98
+6% +$81.1K 0.52% 34
2024
Q3 		$1.34M Buy
1,511
+297
+24% +$267K 0.58% 30
2024
Q2 		$1.1M Sell
1,214
-20
-2% -$16K 0.54% 30
2024
Q1 		$960K Sell
1,234
-343
-22% -$244K 0.52% 33
2023
Q4 		$919K Sell
1,577
-194
-11% -$113K 0.66% 32
2023
Q3 		$951K Sell
1,771
-58
-3% -$29.9K 0.87% 29
2023
Q2 		$858K Buy
+1,829
New +$767K 0.97% 23

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invenio Wealth Partners's LLY Position: Q2 2026 in Review

Invenio Wealth Partners increased its Eli Lilly (LLY) stake by 1.8% in Q2 2026, buying an estimated $21.5K and bringing the position to 1,173 shares worth $1.41M. The position accounts for 0.5% of the portfolio, ranked #31.

Invenio Wealth Partners first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Invenio Wealth Partners held 1,173 shares of Eli Lilly worth $1.41M as of Q2 2026.
  • Invenio Wealth Partners bought 21 Eli Lilly shares in Q2 2026, an estimated $21.5K.
  • Eli Lilly made up 0.5% of Invenio Wealth Partners's portfolio in Q2 2026, its #31 holding.
  • Invenio Wealth Partners first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Invenio Wealth Partners's 13F filing for Q2 2026, filed 30 Jul 2026.